Treatment of gastrointestinal neuroendocrine tumours
Intended for healthcare professionals
CPD Previous     Next

Treatment of gastrointestinal neuroendocrine tumours

Louise Causer Clinical nurse specialist in nuclear medicine, Royal Marsden NHS Foundation Trust, Sutton, Surrey
Barbara King Neuroendocrine tumour and research liaison nurse, Basingstoke and North Hampshire NHS Foundation Trust

Neuroendocrine tumours are rare, accounting for only 0.5 per cent of all malignancies. This is an often misdiagnosed and under-recognised condition that can lead to years of inadequately managed symptoms, leaving patients feeling distressed, isolated and frustrated. The nurse specialist can educate patients, co-ordinate and implement integrated care and administer symptomatic treatments. A major goal is to improve patients’ experiences by working with all members of the multidisciplinary team.

Cancer Nursing Practice. 9, 7, 28-37. doi: 10.7748/cnp2010.

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Want to read more?

Already have access? Log in


3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more